Dermatologist

Dr. Stephanie Fabbro is a board-certified dermatologist and the founder of Rixis Dermatology, a private dermatology practice based in Columbus, Ohio. She brings over a decade of clinical and academic experience to her role as a Principal Investigator and has a particular interest in advancing therapies in cutaneous T-cell lymphoma (CTCL), acne, inflammatory skin disease, and ethical innovation in dermatology research.

Dr. Fabbro has served as a core faculty member for the OhioHealth Dermatology Residency Program since 2016 and holds academic appointments at Northeast Ohio Medical University as Assistant Professor of Internal Medicine. She has authored more than 40 peer-reviewed publications and textbook chapters, with ongoing contributions to dermatology ethics, clinical education, and translational research.

Her clinical trials experience includes work as Principal Investigator on the SIGNAL MF trial (Castle Biosciences) and co-investigator on the MAVORIC and AR-42 trials at The Ohio State University. She is skilled in regulatory compliance, informed consent, and complex trial coordination, and she has served on and chaired multiple ethics committees.

Dr. Fabbro is currently recruiting for industry-sponsored and investigator-initiated trials through her practice’s dedicated research division. Rixis Dermatology offers a diverse patient population, high recruitment potential, and access to a full suite of dermatologic services, including surgical, medical, and image-guided superficial radiation therapy (IG-SRT).